CHU de Québec-Université Laval

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Childhood cancers1 trial
• Frontotemporal dementia1 trial
• Prostate cancer1 trial
• Stroke1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Terminated2 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Canadian Urologic Oncology Group1 trial
• Ottawa Hospital Research Institute1 trial
• Simon Ducharme, MD1 trial
• University of Calgary1 trial

Running trials

• Recruiting

  COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

  NCT04642430· Phase 4· Ottawa Hospital Research Institute· Source

  Contact: Eric Mercier, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Stroke1 recruiting

Closed trials

• Terminated

  Nabilone for Agitation in Frontotemporal Dementia

  NCT05742698· Phase 2· Simon Ducharme, MD· Source

• Terminated

  Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome

  NCT03031821· Phase 3· Canadian Urologic Oncology Group· Source

• Completed

  Re-Irradiation of Progressive or Recurrent DIPG

  NCT03126266· University of Calgary· Source